Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
Egberts F, Gutzmer R, Ugurel S, Becker JC, Trefzer U, Degen A, Schenck F, Frey L, Wilhelm T, Hassel JC, Schadendorf D, Livingstone E, Mauch C, Garbe C, Berking C, Rass K, Mohr P, Kaehler KC, Weichenthal M, Hauschild A. Egberts F, et al. Among authors: schenck f. Ann Oncol. 2011 Jul;22(7):1667-1674. doi: 10.1093/annonc/mdq648. Epub 2011 Jan 10. Ann Oncol. 2011. PMID: 21220519 Clinical Trial.
Therapeutic use of erythropoietin in dermatooncology.
Satzger I, Schenck F, Thol F, Ganser A, Kapp A, Gutzmer R. Satzger I, et al. Among authors: schenck f. J Dtsch Dermatol Ges. 2007 Apr;5(4):280-5. doi: 10.1111/j.1610-0387.2007.06203.x. J Dtsch Dermatol Ges. 2007. PMID: 17376091 Review. English, German.
[Cutaneous side effects of medical tumor therapy].
Degen A, Alter M, Schenck F, Kapp A, Gutzmer R. Degen A, et al. Among authors: schenck f. Hautarzt. 2011 Jun;62(6):444-50. doi: 10.1007/s00105-010-2042-4. Hautarzt. 2011. PMID: 21503784 German.
101 results